Shoulder and arm morbidity in sentinel node-negative breast cancer patients: A systematic review

Breast Cancer Research and Treatment

Volumn 144, Issue 1, 2014, Pages 21-31

  Verbelen, Hanne ^a   Gebruers, Nick ^a   Eeckhout, Fau Mei ^a   Verlinden, Kim ^a   Tjalma, Wiebren ^b,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Breast neoplasms; Morbidity; Review; Sentinel lymph node biopsy

Indexed keywords

ABDUCTION; ADULT; AGED; ARM DISEASE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; DISEASE COURSE; HUMAN; HUMAN TISSUE; INCIDENCE; JOINT MOBILITY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MORBIDITY; MUSCLE WEAKNESS; PARESTHESIA; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANGE OF MOTION; REVIEW; SENSORY DYSFUNCTION; SENTINEL LYMPH NODE BIOPSY; SENTINEL NODE NEGATIVE BREAST CANCER; SHOULDER DISEASE; SYSTEMATIC REVIEW; VERY ELDERLY;

ARM; BREAST NEOPLASMS; FEMALE; HUMANS; MORBIDITY; SENTINEL LYMPH NODE BIOPSY; SHOULDER;

EID: 84896721584     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2846-5     Document Type: Review

References (34)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592
2. Kootstra JJ, Hoekstra-Weebers JEHM, Rietman JS, de Vries J, Baas PC, Geertzen JHB et al (2010) A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol 17:2384-2394
3. Brar P, Jain S, Singh I (2011) Complications of axillary lymph node dissection in treatment of early breast cancer: a comparison of MRM and BCS. Indian J Surg Oncol 2:126-132
4. Liu C, Guo Y, Shi J, Sheng Y (2009) Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer 45:1560-1568
5. Bergmann A, Mendes VV, de Almeida Dias R, do Amaral Silva EB, da Costa Leite Ferreira MG, Fabro EAN (2012) Incidence and risk factors for axillary web syndrome after breast cancer surgery. Breast Cancer Res Treat 131:987-992
6. Aerts PDM, De Vries J, Van der Steeg FW, Roukema JA (2011) The relationship between morbidity after axillary surgery and long-term quality of life in breast cancer patients: the role of anxiety. Eur J Surg Oncol 37:344-349
7. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111-118
8. Belmonte R, Garin O, Segura M, Pont A, Escalada F, Ferrer M (2012) Quality-of-life impact of sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients. Value Health 15:907-915
9. Rietman JS, Dijkstra PU, Geertzen JHB, Baas P, de Vries J, Dolsma WV et al (2004) Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11:1018-1024
10. Rietman JS, Geertzen JHB, Hoekstra HJ, Baas P, Dolsma WV, de Vries J et al (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32:148-152
11. Rietman JS, Dijkstra PU, Geertzen JHB, Baas P, De Vries J, Dolsma W et al (2003) Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast carcinoma. Cancer 98:690-696
12. Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN et al (2010) Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. J Clin Oncol 28:3929-3936
13. Favarao KU, Mantse JC, Barros AC (2010) Shoulder mobility after axillary sentinel lymph node biopsy for early infiltrating breast cancer treatment. Eur J Gynaecol Oncol 31:23-26
14. Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE (2008) Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 15:1996-2005
15. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452-461
16. Husen M, Paaschburg B, Flyger HL (2006) Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15:620-628
17. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A (2006) Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 29:109-119
18. Kootstra JJ, Dijkstra PU, Rietman H, de Vries J, Baas P, Geertzen JHB et al (2013) A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat 139:125-134
19. Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E (2005) Uzan: subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 92:17-22
20. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM et al (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279-293
21. Rönkä R, von Smitten K, Tasmuth T, Leidenius M (2005) One-year morbidity after sentinel node biopsy and breast surgery. Breast 14:28-36
22. Langer S, Guenther JM, Haigh PI, Difronzo LA (2004) Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 70:881-885
23. Arnaud S, Houvenaeghel G, Moutardier V, Butarelli M, Martino M, Tallet A et al (2004) Patients' and surgeons' perspectives on axillary surgery for breast cancer. Eur J Surg Oncol 30:735-743
24. Peintinger F, Reitsamer R, Stranzl H, Ralph G (2003) Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89:648-652
25. Leidenius M, Leppänen E, Krogerus L, von Smitten K (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185:127-130
26. Haid A, Köberle-Wührer R, Knauer M, Burtscher J, Fritzsche H, Peschina W et al (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31-36
27. Haid A, Kuehn T, Konstantiniuk P, Köberle-Wührer R, Knauer M, Kreienberg R et al (2002) Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28:705-710
28. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23-27
29. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312-4321
30. Helms G, Kühn T, Moser L, Remmel E, Kreienberg R (2009) Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection-data from a prospective randomised trial. Eur J Surg Oncol 35:696-701
31. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599-609
32. Swenson KK (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9:745-753
33. Wernicke AG, Shamis M, Sidhu KK, Turner BC, Goltser Y, Khan I et al (2013) Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance. Am J Clin Oncol 36:12-19
34. Srivastava V, Basu S, Shukla VK (2012) Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer 15:373-380